Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background: Major depressive disorder (MDD) is associated with maladaptive self-reported interoception, i.e., abnormal bodily self-experience. Although diminished body trusting predicts suicidal ideation, interoceptive measures have not been considered in depressed inpatients, whose suicide risk regularly peaks post-discharge. This study aims to explore interoceptive characteristics at admission that help identify inpatients at risk for suicidal ideation at discharge, thereby preventing fatal outcomes. Methods: The observational study included 87 depressed inpatients providing self-ratings at both hospital admission (T0) and discharge (T1) on the following scales: Multidimensional Assessment of Interoceptive Awareness (MAIA-2); Beck Depression Inventory-II (BDI-II). A hierarchical logistic regression analysis estimated the longitudinal association between self-reported interoception (T0) and suicidal ideation (T1). The optimal cutpoints for predicting suicidal ideation were calculated using ROC curve analysis. Results: Suicidal ideation was found in 17.24% patients at discharge, who reported lower baseline MAIA-2 Trusting scores than non-ideators (p=0.01). Diminished body trusting (OR=0.19), somatic comorbidity (OR=16.77), and baseline suicidal ideation (OR=24.01) significantly predicted suicidal ideation (T1). For body trusting, we estimated an optimal classification of subsequent suicidal ideation for the cutpoint≤2.33 (AUC=0.70 [95% CI 0.57, 0.83], sensitivity=0.87, specificity=0.44, positive predictive value=0.25, negative predictive value=0.94). Limitations: Due to the exploratory nature of the study, the findings should be replicated in pre-registered trials with larger sample sizes. Conclusions: Diminished body trusting is, with acceptable sensitivity, a significant predictor for post-treatment suicidal ideation in depressed inpatients. This finding emphasizes the importance of incorporating body-centered approaches into multimodal treatment strategies especially in inpatients under risk to prevent suicidal incidents.
Background: Major depressive disorder (MDD) is associated with maladaptive self-reported interoception, i.e., abnormal bodily self-experience. Although diminished body trusting predicts suicidal ideation, interoceptive measures have not been considered in depressed inpatients, whose suicide risk regularly peaks post-discharge. This study aims to explore interoceptive characteristics at admission that help identify inpatients at risk for suicidal ideation at discharge, thereby preventing fatal outcomes. Methods: The observational study included 87 depressed inpatients providing self-ratings at both hospital admission (T0) and discharge (T1) on the following scales: Multidimensional Assessment of Interoceptive Awareness (MAIA-2); Beck Depression Inventory-II (BDI-II). A hierarchical logistic regression analysis estimated the longitudinal association between self-reported interoception (T0) and suicidal ideation (T1). The optimal cutpoints for predicting suicidal ideation were calculated using ROC curve analysis. Results: Suicidal ideation was found in 17.24% patients at discharge, who reported lower baseline MAIA-2 Trusting scores than non-ideators (p=0.01). Diminished body trusting (OR=0.19), somatic comorbidity (OR=16.77), and baseline suicidal ideation (OR=24.01) significantly predicted suicidal ideation (T1). For body trusting, we estimated an optimal classification of subsequent suicidal ideation for the cutpoint≤2.33 (AUC=0.70 [95% CI 0.57, 0.83], sensitivity=0.87, specificity=0.44, positive predictive value=0.25, negative predictive value=0.94). Limitations: Due to the exploratory nature of the study, the findings should be replicated in pre-registered trials with larger sample sizes. Conclusions: Diminished body trusting is, with acceptable sensitivity, a significant predictor for post-treatment suicidal ideation in depressed inpatients. This finding emphasizes the importance of incorporating body-centered approaches into multimodal treatment strategies especially in inpatients under risk to prevent suicidal incidents.
This study focuses on the treatment of obsessive-compulsive disorder (OCD), and in particular the effect of Acceptance and Commitment Therapy (ACT) method will be examined. Obsessive-Compulsive Disorder (OCD) is a condition consisting of disturbing mental obsessions in which the person is excessively worried or unwanted thoughts or impulses are constantly repeated, and compulsions, which are repetitive behaviours to eliminate these obsessions. Compulsions manifest themselves as behaviours such as repeating certain rules, patterns or rituals, checking or cleaning a certain number of times. Individuals with OCD experience serious problems in their daily lives because of these thoughts and behaviours. Acceptance and Commitment Therapy (ACT) is a type of psychotherapy that focuses on the person's inner experiences as part of the cognitive behavioural therapy approach. ACT aims to help the person to accept disturbing thoughts, feelings and physical sensations quietly and with understanding, and to cope with them in a more flexible way. Research shows that ACT is effective in reducing OCD symptoms and is therefore considered as an effective therapy option in the treatment of OCD. Furthermore, it should focus on how the integration and combination of ACT with other treatment modalities can benefit in the field of OCD treatment. In this way, more effective and personalised methods can be developed in the treatment of OCD patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.